kyvero
Market leaders

HSIC

Henry Schein, Inc. (HSIC)

Healthcare • Medical Distribution

StockNasdaqGSUnited StatesUS8064071025

86.43 USD +0.33% today Updated 13 Nov 2026 14:38

Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Henry Schein, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.

Price history

Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.

All time

Updated 13 Nov 2026 14:38. Information, not advice. Showing the last 12 months. Create a free account to see the whole history

Results

Next results 23 Feb 2027 in 102 days · 08:00 · estimate 1.40
Last results 1.37 vs 1.36 estimated 03 Nov 2026 · In line +0.9%
Beat the estimate 8 of 12 3 missed · 1 in line
Average surprise +2.2% reported against the estimate, last 12 quarters

Earnings per share: estimate and reported

27 Feb 2024: estimate 0.70 27 Feb 2024: reported 0.66 02/24 07 May 2024: estimate 1.01 07 May 2024: reported 1.10 05/24 06 Aug 2024: estimate 1.22 06 Aug 2024: reported 1.23 08/24 05 Nov 2024: estimate 1.17 05 Nov 2024: reported 1.22 11/24 25 Feb 2025: estimate 1.21 25 Feb 2025: reported 1.19 02/25 05 May 2025: estimate 1.11 05 May 2025: reported 1.15 05/25 05 Aug 2025: estimate 1.19 05 Aug 2025: reported 1.10 08/25 04 Nov 2025: estimate 1.28 04 Nov 2025: reported 1.38 11/25 24 Feb 2026: estimate 1.29 24 Feb 2026: reported 1.34 02/26 05 May 2026: estimate 1.22 05 May 2026: reported 1.32 05/26 04 Aug 2026: estimate 1.24 04 Aug 2026: reported 1.27 08/26 03 Nov 2026: estimate 1.36 03 Nov 2026: reported 1.37 11/26

Estimate Reported: beat Reported: miss In line

Quarterly results

DateEPS estimateEPS reportedSurpriseResult
23 Feb 2027 08:00 1.40 — — Upcoming
03 Nov 2026 06:00 1.36 1.37 +0.9% In line
04 Aug 2026 06:00 1.24 1.27 +2.5% Beat
05 May 2026 06:00 1.22 1.32 +8.4% Beat
24 Feb 2026 06:00 1.29 1.34 +3.5% Beat
04 Nov 2025 06:00 1.28 1.38 +7.9% Beat
05 Aug 2025 06:00 1.19 1.10 -7.6% Miss
05 May 2025 06:00 1.11 1.15 +3.6% Beat
25 Feb 2025 06:00 1.21 1.19 -1.6% Miss
05 Nov 2024 06:00 1.17 1.22 +4.5% Beat
06 Aug 2024 06:00 1.22 1.23 +1.0% Beat
07 May 2024 06:00 1.01 1.10 +8.6% Beat
27 Feb 2024 06:00 0.70 0.66 -5.2% Miss
13 Nov 2023 06:00 1.32 1.32 +0.2% In line
07 Aug 2023 06:00 1.28 1.31 +2.6% Beat
09 May 2023 06:00 1.23 1.21 -1.9% Miss
16 Feb 2023 06:00 1.22 1.35 +10.7% Beat
01 Nov 2022 06:00 1.14 1.15 +1.3% Beat
02 Aug 2022 06:00 1.16 1.16 -0.1% In line
03 May 2022 06:00 1.19 1.30 +9.4% Beat
15 Feb 2022 06:00 0.91 1.07 +17.1% Beat
02 Nov 2021 06:00 0.96 1.10 +14.8% Beat
03 Aug 2021 06:00 0.98 1.11 +13.7% Beat
04 May 2021 06:00 0.84 1.24 +47.3% Beat
17 Feb 2021 06:00 0.99 1.00 +0.9% In line
02 Nov 2020 07:00 0.80 1.03 +28.9% Beat
04 Aug 2020 07:00 -0.12 — +100.0% —
05 May 2020 08:00 0.74 0.94 +27.5% Beat
20 Feb 2020 07:00 0.91 0.97 +6.5% Beat
05 Nov 2019 07:00 0.86 0.90 +5.1% Beat
06 Aug 2019 07:00 0.83 0.84 +1.4% Beat
07 May 2019 06:00 0.76 0.80 +5.1% Beat
20 Feb 2019 07:00 1.11 1.12 +1.0% In line
06 Nov 2018 07:00 1.01 1.03 +2.4% Beat
06 Aug 2018 07:00 1.01 1.04 +2.6% Beat
08 May 2018 07:00 0.92 0.95 +3.1% Beat
20 Feb 2018 06:00 0.97 0.97 +0.1% In line
06 Nov 2017 07:00 0.89 0.87 -2.6% Miss
08 Aug 2017 07:00 0.87 0.88 +0.5% In line
09 May 2017 07:00 0.82 0.88 +6.8% Beat
21 Feb 2017 07:00 0.92 0.94 +2.0% Beat
02 Nov 2016 07:00 0.83 0.84 +1.7% Beat
04 Aug 2016 07:00 0.81 0.82 +0.7% In line
03 May 2016 07:00 0.69 0.71 +1.7% Beat
10 Feb 2016 07:00 0.82 0.84 +1.4% Beat
04 Nov 2015 06:00 0.74 0.78 +5.3% Beat
29 Jul 2015 07:00 0.73 0.73 -0.2% In line
04 May 2015 07:00 0.63 0.64 +1.0% In line
11 Feb 2015 07:00 0.75 0.78 +4.1% Beat
06 Nov 2014 07:00 0.65 0.67 +2.4% Beat

Annual results · USD

YearRevenueChangeNet income Net marginEPSEPS changeFree cash flow
2025 13.2B +4.0% 398M 3.0% 3.27 +7.2% 521M
2024 12.7B +2.7% 390M 3.1% 3.05 -3.5% 661M
2023 12.3B -2.4% 416M 3.4% 3.16 -19.2% 313M
2022 12.6B — 538M 4.3% 3.91 — 474M

Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.

Prices by day, week and month

Price history in USD, by month
PeriodOpening priceHighLow Closing priceChangeVolumeDividend
Nov 2026 In progress 85.93 89.68 81.03 86.43 +1.82% 19,151,675
Oct 2026 83.96 88.13 79.37 84.88 +1.08% 26,916,600
Sep 2026 89.80 91.69 83.86 83.97 -6.49% 23,251,700
Aug 2026 86.35 92.18 85.73 89.80 +4.72% 24,213,800
Jul 2026 83.47 89.34 82.34 85.75 +2.67% 29,471,100
Jun 2026 76.04 85.19 75.44 83.52 +9.06% 28,662,400
May 2026 74.83 78.04 68.70 76.58 +2.67% 37,615,500
Apr 2026 73.70 81.10 71.31 74.59 +1.21% 21,539,400
Mar 2026 80.83 82.35 71.24 73.70 -10.55% 27,495,800
Feb 2026 75.47 89.29 73.08 82.39 +9.15% 31,905,300
51 older periods: create a free account to see the whole history

Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.

News

Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.

Key data

Previous close
86.14 USD
Market cap
9.5B
Exchange
NasdaqGS
Country
United States
Sector
Healthcare
Industry
Medical Distribution
Currency
USD

Dividends

No dividends on record.

Why this score

How the score is made up
Part of the scorePointsWhy
Business growth Yearly growth of revenue and of earnings per share. 1.2 / 25
  • Revenue growth of 1.4% a year
  • Earnings per share growth of -5.8% a year
Quality Return on equity, net margin and how stable the margins are. 10.7 / 25
  • ROE of 9%
Financial strength Net debt against operating earnings, interest cover and free cash flow. 13.4 / 20
  • Net debt is 3.4× EBITDA
  • Free cash flow yield of 4.9%
Valuation Free cash flow yield and the P/E against its sector. 13.0 / 15
  • P/E 23.6 against 30.6 for its sector
Analysts How far the analysts' average target is from today's price. 7.3 / 10
  • Analysts' target is +12% from the price
  • Total debt has risen three years in a row

Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A). Warnings take 6 points off.

Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio. How the score works

Figures

Valuation
FigureValueReading Sector median
P/E (trailing) 23.6× Fair 30.56×
P/E (forward) 14.34× Good 14.16×
Price / book 3.01× Weak 3.5×
Price / sales 0.69× Good 3.33×
EV / EBITDA 13.49× Fair 11.19×
Free cash flow yield 4.9% Fair 2.1%
Quality
FigureValueReading Sector median
Gross margin 31.6% Fair 54.9%
Operating margin 5.8% Weak 5.8%
Net margin 3.1% Weak 1.2%
Return on equity 9.2% Fair 4.4%
Return on assets 4.4% Fair 2.7%
Growth
FigureValueReading Sector median
Revenue growth / year 1.4% Weak 10.1%
EPS growth / year -5.8% Weak 10.2%
Financial health
FigureValueReading Sector median
Debt / equity 0.82× Fair 0.4×
Net debt / EBITDA 3.38× Weak 1.46×
Interest cover 5.05× Fair 2.17×
Current ratio 1.33× Fair 2.64×
Dividends
FigureValueReading Sector median
Payout of earnings 0% Weak 0%

The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.

Similar shares

Follow HSIC and get alerts

Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.

Start for free Log in